Semi-Annual Consolidated Statement Of Cash Flows

K Pharma,Inc. - Filing #7543861

Concept As at
2023-06-30
2023-01-01 to
2023-06-30
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
614,528,000 JPY
-390,526,000 JPY
-229,119,000 JPY
Depreciation
JPY
6,803,000 JPY
Impairment losses
36,497,000 JPY
31,293,000 JPY
8,226,000 JPY
Interest and dividend income
-7,000 JPY
-7,000 JPY
-1,000 JPY
Interest expenses
JPY
4,000 JPY
Decrease (increase) in inventories
1,250,000 JPY
-313,000 JPY
-18,000 JPY
Increase (decrease) in trade payables
99,005,000 JPY
7,468,000 JPY
-119,000 JPY
Other, net
91,000 JPY
90,000 JPY
JPY
Subtotal
850,421,000 JPY
-362,909,000 JPY
-196,221,000 JPY
Interest and dividends received
7,000 JPY
7,000 JPY
1,000 JPY
Interest paid
JPY
-4,000 JPY
Income taxes paid
-1,899,000 JPY
-580,000 JPY
-96,000 JPY
Net cash provided by (used in) operating activities
848,528,000 JPY
-363,482,000 JPY
-196,320,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-9,781,000 JPY
-29,958,000 JPY
JPY
Other, net
-220,000 JPY
-250,000 JPY
Net cash provided by (used in) investing activities
-9,781,000 JPY
-32,737,000 JPY
-250,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
1,544,375,000 JPY
398,201,000 JPY
Net cash provided by (used in) financing activities
-90,000 JPY
1,544,285,000 JPY
368,201,000 JPY
Other, net
-90,000 JPY
JPY
Net increase (decrease) in cash and cash equivalents
838,656,000 JPY
1,148,065,000 JPY
171,630,000 JPY
Cash and cash equivalents
2,175,504,000 JPY
1,336,847,000 JPY
188,782,000 JPY
17,151,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.